• Ownership of 12 phase I-III global trials; oversight of study start up for >250 sites across North America• Recognized for achieving aggressive site feasibility timelines without sacrificing quality• Educated top-tier KOLs about protocol in a creative and thought provoking manner• Gathered physician insight regarding study protocol that may prohibit patient participation and proposed protocol changes to study teams to maximize patient enrollment• Strategically selected… Show more • Ownership of 12 phase I-III global trials; oversight of study start up for >250 sites across North America• Recognized for achieving aggressive site feasibility timelines without sacrificing quality• Educated top-tier KOLs about protocol in a creative and thought provoking manner• Gathered physician insight regarding study protocol that may prohibit patient participation and proposed protocol changes to study teams to maximize patient enrollment• Strategically selected well-performing sites by tapping into global study teams, medical affairs and fellow colleagues for insight• Accurately established start up timelines and milestones by using past data metrics• Continuously adapted in a rapidly evolving environment, resulting in successful initiation of key trial sites within target timelines• Efficiently initiated CDAs, prepared ethics submission, localized consents, negotiated budgets, quality check of regulatory documents, ensured safety reporting in place, etc.• Regularly conducted internal checks ensuring sponsor and sites are GCP compliant and audit ready• Took pride in elevating knowledge on regulatory/safety requirements by completing trainings before deadline• Proactively endorsed and integrated Roche values into daily work, with the objective to work with agility• Reputation for triggering fruitful discussions around study metrics used to optimize efficiency• Selected by manager to represent division as ‘agility ambassador’ to advocate company values Show less

• Exceeded recruitment objectives for two national longitudinal clinical and biologic studies in arthritis• Engaged 10 lead pediatric rheumatologists and 15+ supporting clinic staff to recruit patients in a competitive enrolment environment• Achieved physician buy-in through educational initiatives and maintained study momentum by routinely presenting study objectives/progress at departmental meetings• Promoted patient interest by preparing patient friendly study material (ie… Show more • Exceeded recruitment objectives for two national longitudinal clinical and biologic studies in arthritis• Engaged 10 lead pediatric rheumatologists and 15+ supporting clinic staff to recruit patients in a competitive enrolment environment• Achieved physician buy-in through educational initiatives and maintained study momentum by routinely presenting study objectives/progress at departmental meetings• Promoted patient interest by preparing patient friendly study material (ie. brochures, flyers, etc.)• Strong leadership demonstrated through launch of multi-site biomarker and genetic study• Strategically selected 11 sites based on past performance and access to target patient population• Successfully provide support to all sites as the single point-of-contact; established valuable relationships with sites that were leveraged for future studies• Member of department research council who championed scorecard to monitor study targets Show less

• Oversaw a large psoriatic arthritis (PsA) and ankylosing spondylitis (AS) Research Program- resulted in 4 publications and abstracts.• Facilitated DNA sample collection and analysis of Salmonella study data leading to a published paper.• Prepared posters for Annual Ogryzlo Day and Toronto Western Hospital Research Day.• Key member in organizing annual patient symposium geared to educating families about arthritis and received exceptional feedback through patient survey.